INS and type 2 diabetes mellitus: In a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes 2, 5, 10 mg NGM282 (sc injection once daily for 12 weeks) did not correct hyperglycemia while a significant improvement in insulin sensitivity was observed at the high dose at the end of the study (183).